Medical device company Zimmer Biomet (NYSE:ZBH) announced better-than-expected revenue in Q2 CY2026, with sales up 4.8% year on year to $2.18 billion. Its non-GAAP profit of $2.07 per share was 3% above analysts’ consensus estimates.

How each outlet headlined it

• StockStory

  Medical device company Zimmer Biomet (NYSE:ZBH) announced better-than-expected revenue in Q2 CY2026, with sales up 4.8% year on year to $2.18 billion. Its non-GAAP profit of $2.07 per share was 3% above analysts’ consensus estimates.
• Investing.com Stocks center

  Why is Zimmer Biomet stock surging today?